BR vs DMAAR · P/E 16, rev $7.48B vs $1.8M cap
Broadridge Financial Solutions Inc (BR) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
DMAAR does not have a complete income-statement cache yet.
BR currently screens at market cap $17.65B and trailing P/E 16.3. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the BR and DMAAR stock pages for the full models.
Not investment advice.